Nadolol
- Product NDC
- 68001-692
- 11-digit product format
- 680010692
- Labeler code
- 68001
- Product ID
- 68001-692_523bc484-5130-b603-e063-6394a90a55ae
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Nadolol
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- BluePoint Laboratories
- Application
- ANDA201893
- Marketing category
- ANDA
- Marketing start
- 2026-02-25
- Substance
- NADOLOL
- Active strength
- 80 mg/1
- Pharmacologic classes
- Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2027-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Nadolol
- Listing expiration
- 2027-12-31
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| NADOLOL | 80 mg/1 |
Harmonized Identifiers#
Field, Values table| Field | Values |
|---|
| Unii | FEN504330V |
| Rxcui | 198006, 198007, 198008 |
DailyMed Product Concepts#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 68001-692-00 | Nadolol | 100 in 1 BOTTLE | TABLET | 100 | | 2 |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Sample | Exclude flag | Status |
|---|
| 68001-692-00 | 68001069200 | 100 TABLET in 1 BOTTLE (68001-692-00) | 100 tablet | 2026-02-25 | No | No | Current |